Evidence map›Paper›PMID 36553888›Full record

ReviewHealthcare (Basel, Switzerland)2022

A Systematic Review and Quality Evaluation of Studies on Long-Term Sequelae of COVID-19.

Jorge Vásconez-González, Juan S Izquierdo-Condoy, Raul Fernandez-Naranjo, Esteban Ortiz-Prado

Abstract readReview
In one paragraph

Review in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jorge Vásconez-GonzálezOne Health Research Group, Faculty of Health Science, Universidad de Las Américas, Quito 170507, Ecuador.
Juan S Izquierdo-CondoyOne Health Research Group, Faculty of Health Science, Universidad de Las Américas, Quito 170507, Ecuador.ORCID 0000-0002-1178-0546
Raul Fernandez-NaranjoOne Health Research Group, Faculty of Health Science, Universidad de Las Américas, Quito 170507, Ecuador.
Esteban Ortiz-PradoOne Health Research Group, Faculty of Health Science, Universidad de Las Américas, Quito 170507, Ecuador.ORCID 0000-0002-1895-7498

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 made its debut as a pandemic in 2020; since then, more than 607 million cases and at least 6.5 million deaths have been reported worldwide. While the burden of disease has been described, the long-term effects or chronic sequelae are still being clarified. The aim of this study was to present an overview of the information available on the sequelae of COVID-19 in people who have suffered from the infection. A systematic review was carried out in which cohort studies, case series, and clinical case reports were included, and the PubMed, Scielo, SCOPUS, and Web of Science databases were extracted. Information was published from 2020 to 1 June 2022, and we included 26 manuscripts: 9 for pulmonary, 6 for cardiac, 2 for renal, 8 for neurological and psychiatric, and 6 for cutaneous sequelae. Studies showed that the most common sequelae were those linked to the lungs, followed by skin, cutaneous, and psychiatric alterations. Women reported a higher incidence of the sequelae, as well as those with comorbidities and more severe COVID-19 history. The COVID-19 pandemic has not only caused death and disease since its appearance, but it has also sickened millions of people around the globe who potentially suffer from serious illnesses that will continue to add to the list of health problems, and further burden healthcare systems around the world.

Indexed as

COVID-19long COVID-19SARS-CoV-2sequelaesystematic review

Identifiers

PMID36553888
PMCPMC9778202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.